HighTower Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.93M Buy
83,053
+26,552
+47% +$2.55M 0.01% 1027
2026
Q1
$5.86M Buy
56,501
+4,553
+9% +$516K 0.01% 1118
2025
Q4
$5.24M Buy
51,948
+625
+1% +$67.9K 0.01% 1144
2025
Q3
$6.33M Sell
51,323
-2,953
-5% -$367K 0.01% 1045
2025
Q2
$6.52M Sell
54,276
-372,587
-87% -$49.7M 0.01% 987
2025
Q1
$62.9M Buy
426,863
+31,418
+8% +$4.8M 0.09% 246
2024
Q4
$64.2M Buy
395,445
+11,585
+3% +$1.9M 0.09% 240
2024
Q3
$62.5M Buy
383,860
+17,584
+5% +$2.61M 0.09% 233
2024
Q2
$50M Sell
366,276
-5,261
-1% -$731K 0.08% 255
2024
Q1
$56.9M Sell
371,537
-675
-0.2% -$101K 0.09% 236
2023
Q4
$53.1M Buy
372,212
+26,437
+8% +$3.52M 0.09% 235
2023
Q3
$45.3M Buy
345,775
+18,542
+6% +$2.82M 0.09% 236
2023
Q2
$52M Buy
327,233
+21,444
+7% +$3.46M 0.1% 207
2023
Q1
$48.4M Buy
305,789
+21,653
+8% +$3.25M 0.11% 212
2022
Q4
$39.9M Buy
284,136
+26,428
+10% +$3.75M 0.09% 241
2022
Q3
$33.1M Buy
257,708
+13,237
+5% +$1.91M 0.09% 243
2022
Q2
$34.5M Buy
244,471
+79,922
+49% +$11.4M 0.09% 237
2022
Q1
$22.9M Buy
164,549
+114,964
+232% +$17.6M 0.05% 340
2021
Q4
$8.64M Sell
49,585
-1,984
-4% -$331K 0.02% 659
2021
Q3
$8.54M Buy
51,569
+2,545
+5% +$438K 0.02% 602
2021
Q2
$8.82M Sell
49,024
-899
-2% -$164K 0.03% 568
2021
Q1
$9.63M Sell
49,923
-383
-0.8% -$73.7K 0.03% 497
2020
Q4
$10.1M Sell
50,306
-222
-0.4% -$45.9K 0.04% 368
2020
Q3
$10.6M Sell
50,528
-829
-2% -$185K 0.05% 330
2020
Q2
$11.3M Buy
51,357
+4,198
+9% +$839K 0.06% 291
2020
Q1
$8.17M Sell
47,159
-1,306
-3% -$216K 0.05% 318
2019
Q4
$7.44M Sell
48,465
-1,309
-3% -$196K 0.04% 415
2019
Q3
$7.56M Sell
49,774
-2,273
-4% -$359K 0.04% 407
2019
Q2
$7.97M Sell
52,047
-799
-2% -$122K 0.05% 389
2019
Q1
$8.48M Sell
52,846
-6,075
-10% -$942K 0.06% 342
2018
Q4
$9.08M Buy
58,921
+490
+0.8% +$76.3K 0.07% 285
2018
Q3
$8.78M Sell
58,431
-377
-0.6% -$53.6K 0.06% 330
2018
Q2
$7.96M Buy
58,808
+3,923
+7% +$484K 0.06% 344
2018
Q1
$7.31M Buy
54,885
+834
+2% +$112K 0.06% 345
2017
Q4
$8.04M Sell
54,051
-1,937
-3% -$264K 0.07% 320
2017
Q3
$7.38M Buy
55,988
+1,648
+3% +$221K 0.06% 343
2017
Q2
$7.24M Sell
54,340
-301
-0.6% -$40.6K 0.06% 335
2017
Q1
$7.36M Sell
54,641
-4,458
-8% -$577K 0.07% 314
2016
Q4
$7.09M Sell
59,099
-10,330
-15% -$1.22M 0.08% 271
2016
Q3
$8.7M Buy
69,429
+9,909
+17% +$1.3M 0.1% 212
2016
Q2
$8.23M Sell
59,520
-19,857
-25% -$2.57M 0.1% 209
2016
Q1
$10M Sell
79,377
-13,157
-14% -$1.67M 0.03% 191
2015
Q4
$11.7M Buy
92,534
+4,503
+5% +$559K 0.14% 165
2015
Q3
$10.2M Buy
88,031
+53,866
+158% +$6.05M 0.13% 167
2015
Q2
$3.55M Sell
34,165
-42
-0.1% -$4.53K 0.06% 366
2015
Q1
$3.78M Sell
34,207
-13,270
-28% -$1.44M 0.06% 379
2014
Q4
$4.95M Sell
47,477
-16,159
-25% -$1.62M 0.08% 287
2014
Q3
$6.11M Buy
63,636
+908
+1% +$82.1K 0.1% 229
2014
Q2
$5.73M Sell
62,728
-3,791
-6% -$340K 0.1% 220
2014
Q1
$5.85M Buy
66,519
+4,340
+7% +$381K 0.11% 208
2013
Q4
$5.77M Sell
62,179
-4,729
-7% -$426K 0.12% 205
2013
Q3
$5.47M Buy
66,908
+1,702
+3% +$144K 0.14% 179
2013
Q2
$5.42M Buy
+65,206
New +$5.61M 0.15% 162

Other funds holding CLX

HighTower Advisors's CLX Position: Q2 2026 in Review

HighTower Advisors increased its Clorox (CLX) stake by 47% in Q2 2026, buying an estimated $2.55M and bringing the position to 83,053 shares worth $7.93M. The position accounts for 0.01% of the portfolio, ranked #1027.

HighTower Advisors first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $64.2M in Q4 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • HighTower Advisors held 83,053 shares of Clorox worth $7.93M as of Q2 2026.
  • HighTower Advisors bought 26,552 Clorox shares in Q2 2026, an estimated $2.55M.
  • Clorox made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #1027 holding.
  • HighTower Advisors first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Clorox position peaked at $64.2M in Q4 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.